Swasthya Kalyan Hospitals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-07-2024
- Paid Up Capital ₹ 0.72 M
as on 26-07-2024
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.00 M
as on 26-07-2024
- Revenue 6.84%
(FY 2023)
- Profit -22.99%
(FY 2023)
- Ebitda -17.26%
(FY 2023)
- Net Worth 12.94%
(FY 2023)
- Total Assets 0.01%
(FY 2023)
About Swasthya Kalyan Hospitals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.72 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Baijyanti Agarwal, Shyam Agrawal, and Sarvesh Agrawal serve as directors at the Company.
- CIN/LLPIN
U24232RJ1998PTC015054
- Company No.
015054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swasthya Kalyan Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baijyanti Agarwal  | Director | 13-Jul-2020 | Current |
| Shyam Agrawal | Director | 15-Jan-2003 | Current |
| Sarvesh Agrawal | Director | 26-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Swasthya Kalyan Hospitals.
Swasthya Kalyan Hospitals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.84% increase. The company also saw a substantial fall in profitability, with a 22.99% decrease in profit. The company's net worth Soared by an impressive increase of 12.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swasthya Kalyan Hospitals?
In 2023, Swasthya Kalyan Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rajasthan Medical Services Corporation LimitedActive 13 years 7 monthsShyam Agrawal is a mutual person
Swasthyakalyan Securities Private LimitedActive 27 years 7 monthsBaijyanti Agarwal and Shyam Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 16 Mar 2007 | ₹3.00 M | Satisfied |
How Many Employees Work at Swasthya Kalyan Hospitals?
Unlock and access historical data on people associated with Swasthya Kalyan Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swasthya Kalyan Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swasthya Kalyan Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
